Table 3.
Group | No. Of Patients | Months | Average Months Per Patient | Days In TR (%) (95% Confidence Interval) | P-Value | P-Value | No. Of Inr Measurements In TR (%) (95% Confidence Interval) | P-Value | P-Value |
---|---|---|---|---|---|---|---|---|---|
A | 46 | 507.2 | 11.03 | 12,288 (79.7) (79.0–80.3) | <2.2 × 10−16 (A vs. C) | 0.2516 (A vs. B) | 1,635 (78.3) (76.5–80.1) | 1.046 × 10−10 (A vs. C) | 0.0321 (A vs. B) |
B | 37 | 406.0 | 10.97 | 9,904 (80.2) (79.4–80.9) | <2.2 × 10−16 (B vs. C) | — | 2,407 (80.8) (79.3–82.1) | <2.2 × 10−16 (B vs. C) | — |
C | 40 | 461.0 | 11.52 | 10,195 (72.7) (71.9–73.4) | — | — | 616 (67.2) (64.1–70.2) | — | — |
p-values are found with chi-squared test.
TR, therapeutic range.